Hjem › Tykktarmskreft › New York
Kliniske studier for Tykktarmskreft i New York
28 studier for Tykktarmskreft søker deltakere på steder i New York.
Byer i New York
Offisiell studietekst (engelsk)
Family Communications After Genetic Testing
- Glens Falls Hospital, Glens Falls
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07143487Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Montefiore Medical Center-Einstein Campus, The Bronx
- James J Peters VA Medical Center, The Bronx
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07283939A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
- Ellis Hospital ( Site 0098), Schenectady
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06997497Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- NYOH Albany Cancer Center, Albany
- Hematology-Oncology Associates of Central New York, PC, Auburn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- og 12 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07222800Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- NYU Langone Health Perlmutter Cancer Center, New York
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07629960A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Ny Cancer and Blood Specialists, Shirley
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07284849Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Rekrutterer
Alder 45 til 70 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
- The New York Hospital Medical Center of Queens, Flushing
- Glens Falls Hospital, Glens Falls
- og 23 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05174169Shield Post-Approval Study Protocol
- Associated Gastroenterologists of Central New York, Camillus
- Syracuse Gastroenterological Associates, P.C., East Syracuse
- Associated Gastroenterologists of Central New York, Fayetteville
- og 4 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 45 til 81 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06880055Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, New York
- Xencor Investigative Site, New York
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT05433142A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street., New York
- og 1 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07318805EXoPERT EMERALD Clinical Study
- Albany Stratton VA Medical Center, Albany
- Bronx Veterans Medical Research Foundation, The Bronx
- VA Hudson Valley Healthcare System, Wappingers Falls
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 45 og eldre · Alle kjønn · Oppdatert 1. jul. 2026 · NCT07186296Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NYU Langone Medical Center, New York
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT06051695A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, New York
- Research Site, New York
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT06835569Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. jun. 2026 · NCT06040541Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. mai 2026 · NCT05379985Brodalumab in the Treatment of Immune-Related Adverse Events
- Columbia University Irving Medical Center, New York
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT06673329Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
- NYU Langone Health, New York
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 11. mai 2026 · NCT00843375Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
- Memorial Sloan Kettering Cancer Center, New York
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 12. mar. 2026 · NCT04668872Phase II Trial of Lung Chemoemobolization
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT05672108Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
- Roswell Park Comprehensive Cancer Center, Buffalo
RekruttererFase 3
Alder 1 og eldre · Alle kjønn · Oppdatert 4. feb. 2026 · NCT06563388Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- og 1 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alle aldre · Alle kjønn · Oppdatert 23. jan. 2026 · NCT00582621Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jan. 2026 · NCT05855200Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)
- Zuckerberg Cancer Center, New Hyde Park
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jan. 2026 · NCT07361107SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- og 2 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- NYU Langone Health, New York
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT06682793Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.